Video

Opioid and cocaine use epidemic is entrenched within Baltimore city, and there are no FDA-approved treatment for any stimulant disorders.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters

Can a weight-loss drug help treat cocaine addiction?At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters

Can a class of drugs best known for treating diabetes and weight loss also help people struggling with cocaine use disorder?Dr. Sarah Kattakuzhy, an associate professor at the University of Maryland School of Medicine, is leading innovative research on GLP-1 receptor agonists — medications that may offer a new path forward in treating addiction.This NIH-funded research could transform how we understand and address substance use, giving people more options — and more hope.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #AddictionResearch #CocaineUseDisorder #GLP1 #SubstanceUseDisorder #UMBResearch #NIHfunding #HealthInnovation #DrSarahKattakuzhy

Hosted by the University of Maryland Baltimore's Center for Interprofessional Education (CIPE) on April 2, IPE Day brought together more than 170 students from all seven UMB professional schools — including medicine, nursing, pharmacy, law, dentistry, physical therapy, social work, and the Graduate School — for a full afternoon of collaborative learning, simulation activities, and real-life insights into the power of team-based care.Read more: https://www.umaryland.edu/news/archived-news/april-2025/ipe-day-centers-on-listening-to-patients-and-peers.php

The changes and challenges facing academic research and the University of Maryland, Baltimore's response was the topic of Virtual Face to Face on April 10 hosted by James Hughes, MBA, Chief Enterprise and Economic Development Officer and Senior Vice President. Hughes was joined by University of Maryland School of Medicine Professor and Executive Vice Dean Chris O’Donnell, PhD, and E. Albert Reece, MD, PhD, MBA, Director of the Center for Advanced Research Training and Innovation.

On April 1, the legal challenges facing higher education were the subjects of discussion on Virtual Face to Face. Program host and University of Maryland, Baltimore President Bruce E. Jarrell, MD, FACS, spoke with University of Maryland Francis King Carey Dean and Professor Renée; Carey Law Professor Marley Weiss, JD; and Carey Law Assistant Professor Chris Mathis, JD. The program included questions from an audience of 500 UMB faculty, staff, and students.

On Feb. 25, 2025 University of Maryland, Baltimore President Bruce E. Jarrell, MD, FACS, talked with legal scholars from the University of Maryland Francis King Carey School of Law on the program Virtual Face to Face. The guests were Dean and Professor Renée Hutchins Laurent, JD, University System of Maryland Regents Professor Mark Graber, JD, PhD, and the Jeff Sovern, JD, the Michael Millemann Professor of Consumer Law.

University of Maryland, Baltimore (UMB) is Maryland's only public health, law, and human services university. Six professional schools and the School of Graduate Studies confer the majority of health care, human services, and law professional degrees in Maryland each year.

Baltimore Business Journal Publisher Courtney Bode interviews University of Maryland, Baltimore President Bruce E. Jarrell, MD, FACS.

Each year, UMB commemorates the legacy of the Rev. Dr. Martin Luther King Jr.This celebration reinforces UMB’s commitment to diversity, equity, and inclusion. An inspiring keynote message is delivered by a distinguished leader or scholar in the field of diversity, equity, and inclusion.This year’s keynote message is “Fulfilling Dr. King's Legacy from Civil Rights to Economic Rights: Causes, Consequences, and Remedies to Fulfill Economic and Racial Justice.”KEYNOTE SPEAKER: Darrick Hamilton, PhD, Henry Cohen Professor of Economics and Urban Policy and Founding Director of the Institute on Race, Power and Political Economy, The New School, New York City.